Literature DB >> 1910715

Langerhans cells related to prognosis in patients with laryngeal carcinoma.

O Gallo1, G A Libonati, E Gallina, O Fini-Storchi, A Giannini, C Urso, R Bondi.   

Abstract

Intratumoral and peritumoral infiltration of T-zone histiocytes, mainly of mature Langerhans cells, was investigated in 88 patients with squamous cell carcinoma of the larynx by immunohistochemical methods using polyclonal antibodies against S100 protein and lysozyme. Granulocytic and lymphoid inflammatory infiltration and its relationship to the presence of Langerhans cells were also evaluated. Langerhans cells were present within the cancer tissues and showed a relationship with lymphoid infiltrate. No significant correlation was present among the density of Langerhans cells and the site of neoplastic growth (supraglottic or subglottic), granulocytic inflammatory infiltration, histological tumor grade, or clinical stage. Patients with high or intermediate density of Langerhans cells survived longer than those with low density (mean survival, 61%, 62%, and 0%, respectively). The number of Langerhans cells was relevant in patients with evident infiltration of lymphocytes and plasma cells, according to their ability to present antigens to sensitized T cells. Our results indicate that the presence of high or intermediate density of Langerhans cells and of marked lymphoid inflammation may be considered favorable prognostic factors for patients with squamous cell carcinoma of the larynx.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1910715     DOI: 10.1001/archotol.1991.01870210079015

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  15 in total

1.  Distribution of immunocompetent cells in various areas in the normal laryngeal mucosa of the rat.

Authors:  P Jecker; M Ptok; R Pabst; J Westermann
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

2.  p63 and Ki-67 immunostainings in laryngeal squamous cell carcinoma are related to survival.

Authors:  M Re; A Zizzi; L Ferrante; D Stramazzotti; G Goteri; F M Gioacchini; F Olivieri; G Magliulo; C Rubini
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-09       Impact factor: 2.503

Review 3.  Role of Langerhans cells and other dendritic cells in viral diseases.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  In vivo infiltration of mononuclear cells in squamous cell carcinoma of the head and neck correlates with the ability to expand tumour-infiltrating T cells in vitro and with the expression of MHC class I antigens on tumour cells.

Authors:  J Hald; N Rasmussen; M H Claesson
Journal:  Cancer Immunol Immunother       Date:  1994-12       Impact factor: 6.968

Review 5.  The role of transforming growth factor-beta in immune suppression and chronic inflammation of squamous cell carcinomas.

Authors:  Alexander A Strait; Xiao-Jing Wang
Journal:  Mol Carcinog       Date:  2020-04-17       Impact factor: 4.784

6.  Prognostic significance of Ki-67 expression for patients with laryngeal squamous cell carcinoma primarily treated by total laryngectomy.

Authors:  Mustafa Fuat Acikalin; Ulkü Oner; Nilüfer Tel; Ozgül Paşaoğlu; Hamdi Cakli; Ertuğrul Colak
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-11-06       Impact factor: 2.503

7.  Tumour-infiltrating lymphocytes mediate lysis of autologous squamous cell carcinomas of the head and neck.

Authors:  J Hald; N Rasmussen; M H Claesson
Journal:  Cancer Immunol Immunother       Date:  1995-10       Impact factor: 6.968

8.  Clinical significance of langerhans cells in squamous cell carcinoma of the larynx.

Authors:  Francisco Esteban; Francisco Ruiz-Cabello; Miguel Angel Gonzalez-Moles; Miguel Angel Lopez-Gonzalez; Rafael Funez; Maximino Redondo
Journal:  J Oncol       Date:  2012-02-09       Impact factor: 4.375

Review 9.  Immune suppression in head and neck cancers: a review.

Authors:  Anaëlle Duray; Stéphanie Demoulin; Pascale Hubert; Philippe Delvenne; Sven Saussez
Journal:  Clin Dev Immunol       Date:  2011-03-10

10.  Interferon-gamma and interleukin-10 production by mononuclear cells from patients with advanced head and neck cancer.

Authors:  Luiz C Conti-Freitas; Maria C Foss-Freitas; Rui C M Mamede; Norma T Foss
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.